ImageneBio PAO Erin Butler to depart; Bob Lally named as successor

ImageneBio, Inc.

Mutual separation of Erin Butler, SVP Finance & Administration and Principal Accounting Officer, effective March 20, 2026.
Bob Lally, SVP Finance & Operations, appointed as Principal Accounting Officer effective March 20, 2026.
Butler to receive severance per existing Severance Rights Agreement dated October 21, 2024.
Lally previously served at Ikena Oncology (SVP Finance & Operations) and Prevail Therapeutics (VP Finance, COO).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.